Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

@article{Marrero2018DiagnosisSA,
  title={Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases},
  author={Jorge Marrero and Laura Kulik and Claude B. Sirlin and Andrew X. Zhu and Richard S. Finn and Michael M I Abecassis and Lewis Rowland Roberts and Julie K. Heimbach},
  journal={Hepatology},
  year={2018},
  volume={68}
}
Author(s): Marrero, Jorge A; Kulik, Laura M; Sirlin, Claude B; Zhu, Andrew X; Finn, Richard S; Abecassis, Michael M; Roberts, Lewis R; Heimbach, Julie K 

Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study

Limited data exist on the burden and features of non‐cirrhotic hepatocellular carcinoma (HCC) in the United States.

High rates of treatment stage migration for early hepatocellular carcinoma and association with adverse outcomes: An Australian multicenter study

  • K. F. LooR. Woodman A. Wigg
  • Medicine, Biology
    JGH open : an open access journal of gastroenterology and hepatology
  • 2022
TLDR
The prevalence and outcomes of inoperable early HCC patients with contraindications to percutaneous ablation, resulting in treatment stage migration (TSM), are investigated.

Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis

TLDR
This study’s aim was to quantify tumor doubling time (TDT) and identify correlates associated with indolent and rapid growth.

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma

TLDR
This work aimed to investigate the usefulness of PIVKA‐II, AFP,AFP, AFP‐L3, CEA, and their combinations in the diagnosis of primary and metastatic HCC.

Monofocal hepatocellular carcinoma: How much does size matter?

  • F. PelizzaroB. Penzo F. Farinati
  • Medicine, Biology
    Liver international : official journal of the International Association for the Study of the Liver
  • 2020
TLDR
Evaluating the appropriate staging and treatment for large (>5 cm) monofocal hepatocellular carcinoma (HCC) aimed at evaluating the appropriate staged and treatment of large tumours.

Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention

TLDR
This manuscript reviews the various treatment options for HCC with a historically noncurative intent.

Review article: new therapeutic interventions for advanced hepatocellular carcinoma

Advanced hepatocellular carcinoma (HCC) portends a poor prognosis; however recent advances in first‐line and second‐line treatment options should yield significant improvements in survival.
...

References

SHOWING 1-10 OF 196 REFERENCES

AASLD guidelines for the treatment of hepatocellular carcinoma

TLDR
This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about concrete mechanical properties such as E-modulus and compressive strength.

Management of hepatocellular carcinoma: An update

Since the publication of the American Association for the Study of Liver Diseases (AASLD) practice guidelines on the management of hepatocellular carcinoma (HCC) in 2005, new information has emerged

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

TLDR
A systematic review of the evidence that surveillance for hepatocellular carcinoma in patients with cirrhosis improves early detection, receipt of curative treatment, and overall survival is conducted.

Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C

Background : Screening for hepatocellular carcinoma in cirrhotic patients using abdominal ultrasonography and alpha‐foetoprotein levels is widely practiced.

Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America

  • A. ChanD. Balderramo J. Debes
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2017

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis

Abdominal ultrasound fails to detect over one‐fourth of hepatocellular carcinoma (HCC) at an early stage in patients with cirrhosis. Identifying patients in whom ultrasound is of inadequate quality

Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease‐free survival

The aim of this study is to identify the efficacy of portal vein embolization (PVE) before right hepatectomy in patients with hepatocellular carcinoma (HCC) with regard to hepatic function, surgical

Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra‐arterial Therapy

  • J. H. SohnR. Duran J. Geschwind
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2017

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

  • F. KolligsJ. Bilbao B. Sangro
  • Medicine
    Liver international : official journal of the International Association for the Study of the Liver
  • 2015
TLDR
To compare selective internal radiation therapy with transarterial chemoembolization (TACE), the standard‐of‐care for intermediate‐stage unresectable, hepatocellular carcinoma (HCC), as first‐line treatment, selectiveinternal radiation therapy (SIRT) is compared with TACE.
...